# Azacitidine Compared to Conventional Chemotherapy as Consolidation of Elderly Patients With AML

> **NCT01794169** · PHASE2 · TERMINATED · sponsor: **Karolinska University Hospital** · enrollment: 130 (estimated)

## Conditions studied

- Acute Myeloid Leukemia

## Interventions

- **DRUG:** Azacitidine
- **DRUG:** DA

## Key facts

- **NCT ID:** NCT01794169
- **Lead sponsor:** Karolinska University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-03
- **Primary completion:** 2015-09
- **Final completion:** 2018-03
- **Target enrollment:** 130 (ESTIMATED)
- **Why stopped:** Poor recruitment
- **Last updated:** 2015-09-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01794169

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01794169, "Azacitidine Compared to Conventional Chemotherapy as Consolidation of Elderly Patients With AML". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01794169. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*